Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$44.84−1.52 (-3.28%)
Close on Nov 17, 2026Market cap $3.20BP/E –Yield –
Pulse Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pulse Biosciences's profit margin for the twelve months ending Jun 30, 2026 was -6755.8%. For fiscal 2025 it was -20794.6%, against -8357.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -20794.6% | −12436.7 |
| FY2022 | Dec 31, 2022 | -8357.9% | −3868.4 |
| FY2021 | Dec 31, 2021 | -4489.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -5681.3% | −399.8 |
| Q1 FY2026 | Mar 31, 2026 | -4633.7% | −743.4 |
| Q4 FY2025 | Dec 31, 2025 | -6603.4% | −4776.9 |
| Q3 FY2025 | Sep 30, 2025 | -22540.7% | −20052.5 |
| Q2 FY2022 | Jun 30, 2022 | -5281.5% | – |
| Q1 FY2022 | Mar 31, 2022 | -3890.3% | – |
| Q4 FY2021 | Dec 31, 2021 | -1826.5% | – |
| Q3 FY2021 | Sep 30, 2021 | -2488.2% | – |
See a number that looks wrong?